BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19603233)

  • 1. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
    Hwang N; Schiller DE; Crystal P; Maki E; McCready DR
    Ann Surg Oncol; 2009 Nov; 16(11):3000-9. PubMed ID: 19603233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?
    Beck AC; Bayard S; Plitas G; Sevilimedu V; Kuba MG; Garcia P; Morrow M; Tadros AB
    Ann Surg Oncol; 2023 Oct; 30(10):6061-6069. PubMed ID: 37493892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term oncologic outcomes of central lumpectomy and conventional breast-conserving surgery for invasive breast cancer: propensity score matching analysis.
    Jung JJ; Cheun JH; Kim HK; Lee HB; Moon HG; Hwang KT; Han W
    Breast Cancer Res Treat; 2024 Jun; 205(3):465-474. PubMed ID: 38526688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of long-term oncological outcomes after central lumpectomy versus nipple-sparing breast-conserving surgery for centrally located breast cancer: a propensity score-matched study.
    Hwang YH; Yoo TK; Lee SB; Kim J; Chung IY; Ko BS; Kim HJ; Lee JW; Son BH
    Breast Cancer Res Treat; 2024 May; 205(1):117-125. PubMed ID: 38332198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical outcome of patients with core-biopsy-proven nonpalpable breast carcinoma: a large cohort follow-up study.
    van Esser S; Peters NH; van den Bosch MA; Mali WP; Peeters PH; Borel Rinkes IH; van Hillegersberg R
    Ann Surg Oncol; 2009 Aug; 16(8):2252-8. PubMed ID: 19437077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review and Meta-analysis of the Role of Preoperative MRI in In-breast Tumor Recurrence After Breast-Conserving Surgery.
    Carroll MC; Yen RW; Leech M; Barth RJ
    Ann Surg Oncol; 2024 Jun; 31(6):3926-3938. PubMed ID: 38520578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of loco-regional and distant recurrences in breast cancer after conservative surgery.
    Elsayed M; Alhussini M; Basha A; Awad AT
    World J Surg Oncol; 2016 May; 14():144. PubMed ID: 27180041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New criteria to predict tumor recurrence in invasive ductal carcinoma of the breast.
    Nozoe T; Mori E; Iguchi T; Ezaki T
    Int Surg; 2013; 98(4):283-8. PubMed ID: 24229009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer.
    Houssami N; Turner RM; Morrow M
    Breast Cancer Res Treat; 2017 Sep; 165(2):273-283. PubMed ID: 28589366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlocking the Power of the Homing Phenomenon: Why Breast Conserving Surgery Outshines Mastectomy in Overall Survival.
    Mokbel K
    Clin Breast Cancer; 2024 Feb; 24(2):85-92. PubMed ID: 37925361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial.
    Stenmark Tullberg A; Sjöström M; Niméus E; Killander F; Chang SL; Feng FY; Speers CW; Pierce LJ; Kovács A; Lundstedt D; Holmberg E; Karlsson P
    Clin Cancer Res; 2023 May; 29(9):1783-1793. PubMed ID: 37071498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative magnetic resonance imaging use and oncologic outcomes in premenopausal breast cancer patients.
    Zeng Z; Amin A; Roy A; Pulliam NE; Karavites LC; Espino S; Helenowski I; Li X; Luo Y; Khan SA
    NPJ Breast Cancer; 2020; 6():49. PubMed ID: 33083528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Radiation Therapy for the Treatment of Breast Cancer in 2019 Versus 2020.
    Powell AC; Long JW; Bhatnagar AK; Loy BA; Mirhadi AJ
    Adv Radiat Oncol; 2024 Apr; 9(4):101435. PubMed ID: 38778830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of preoperative breast magnetic resonance imaging on surgical decision making and cancer recurrence rates.
    Pediconi F; Miglio E; Telesca M; Luciani ML; Kirchin MA; Passariello R; Catalano C
    Invest Radiol; 2012 Feb; 47(2):128-35. PubMed ID: 21934515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast pain and cancer: should we continue to work-up isolated breast pain?
    Mohallem Fonseca M; Lamb LR; Verma R; Ogunkinle O; Seely JM
    Breast Cancer Res Treat; 2019 Oct; 177(3):619-627. PubMed ID: 31309396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
    Hurvitz SA; Martin M; Symmans WF; Jung KH; Huang CS; Thompson AM; Harbeck N; Valero V; Stroyakovskiy D; Wildiers H; Campone M; Boileau JF; Beckmann MW; Afenjar K; Fresco R; Helms HJ; Xu J; Lin YG; Sparano J; Slamon D
    Lancet Oncol; 2018 Jan; 19(1):115-126. PubMed ID: 29175149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular Neoplasia and Atypical Ductal Hyperplasia on Core Biopsy: Current Surgical Management Recommendations.
    Racz JM; Carter JM; Degnim AC
    Ann Surg Oncol; 2017 Oct; 24(10):2848-2854. PubMed ID: 28766203
    [No Abstract]   [Full Text] [Related]  

  • 18. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
    Kuehn T; Bauerfeind I; Fehm T; Fleige B; Hausschild M; Helms G; Lebeau A; Liedtke C; von Minckwitz G; Nekljudova V; Schmatloch S; Schrenk P; Staebler A; Untch M
    Lancet Oncol; 2013 Jun; 14(7):609-18. PubMed ID: 23683750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
    Farge D; Frere C; Connors JM; Ay C; Khorana AA; Munoz A; Brenner B; Kakkar A; Rafii H; Solymoss S; Brilhante D; Monreal M; Bounameaux H; Pabinger I; Douketis J;
    Lancet Oncol; 2019 Oct; 20(10):e566-e581. PubMed ID: 31492632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Preoperative Immune Modulating Nutrition on Outcomes in Patients Undergoing Surgery for Gastrointestinal Cancer: A Systematic Review and Meta-analysis.
    Adiamah A; Skořepa P; Weimann A; Lobo DN
    Ann Surg; 2019 Aug; 270(2):247-256. PubMed ID: 30817349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.